Athersys Inc (FRA:4LSA)
€ 0.045 0 (0%) Market Cap: 921,000.00 Enterprise Value: 21.92 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Athersys Inc GEN 40: Looking Back and Thinking Ahead Call Transcript

Jan 20, 2021 / 07:00PM GMT
Release Date Price: €33.5 (-4.29%)
Kevin Davies

Hello, everyone. And welcome to the first GEN Live of 2021 on a very auspicious day Inauguration Day for the new administration. So thank you very much for joining us and tearing ourself away from the screen where we've been watching history being made.

I'm Kevin Davies, Editor-at-Large with GEN, Genetic Engineering & Biotechnology News, Executive Editor of The CRISPR Journal and the author of a new book, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing.

I'm joined by 3 of my colleagues, who most of you will have met before, Julianna LeMieux -- Dr. Julianna LeMieux, Alex Philippidis and John Sterling, all editorial colleagues with GEN; and 4 very distinguished guests, who I'll introduce in just a couple of minutes.

The title of today's episode is GEN 40: Looking Back and Thinking Ahead. GEN celebrates its 40th anniversary this year. The magazine has literally written and told the biotech story for the past 4 decades. With COVID-19 vaccines paving the way CRISPR's Nobel Prize and dramatic advances in gene therapy, neuroscience, regenerative

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot